We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
U.S. Bancorp Announces Additional Share Buyback of Up to $2.5B
Read MoreHide Full Article
U.S. Bancorp (USB - Free Report) recently announced an additional share-repurchase program of up to $2.5 billion, following the Fed’s approval.
This adds to June’s buyback authorization of up to $3 billion, which commenced on Jul 1. The company intends to make these repurchases through Jun 30, 2020.
Andy Cecere, chairman, president and CEO of U.S. Bancorp, noted, “This capital distribution reflects our ability to prudently manage capital as we respond to changes in the regulatory landscape, while continuing to invest in our future.”
U.S. Bancorp, along with many other financial institutions, needs to clear Fed’s annual stress tests, in order to get approval for capital plans. Some of these institutions include Bank of America (BAC - Free Report) , JPMorgan (JPM - Free Report) and Goldman Sachs (GS - Free Report) .
Alongside share repurchase, the company is also active in dividend payments. Since 2011, U.S. Bancorp has been raising its dividend consistently. The company’s 2019 capital plan also included a 13.5% hike in quarterly dividend announced in September. Prior to this, it had raised its dividend by 23% last September.
U.S. Bancorp has returned 80% of its earnings to shareholders through dividends and share repurchases as of Sep 30 2019, which is at the higher end of the targeted payout ratio of 60-80%.
Our Take
Driven by a healthy liquidity position, U.S. Bancorp remains well poised to increase shareholders’ wealth through regular dividend payments and share buybacks. Further, the company’s capital-deployment activities look sustainable, given the lower debt/equity ratio compared with its peers, along with robust earnings strength.
Shares of the company have gained 28% so far this year compared with 29.5% growth recorded by the industry.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
U.S. Bancorp Announces Additional Share Buyback of Up to $2.5B
U.S. Bancorp (USB - Free Report) recently announced an additional share-repurchase program of up to $2.5 billion, following the Fed’s approval.
This adds to June’s buyback authorization of up to $3 billion, which commenced on Jul 1. The company intends to make these repurchases through Jun 30, 2020.
Andy Cecere, chairman, president and CEO of U.S. Bancorp, noted, “This capital distribution reflects our ability to prudently manage capital as we respond to changes in the regulatory landscape, while continuing to invest in our future.”
U.S. Bancorp, along with many other financial institutions, needs to clear Fed’s annual stress tests, in order to get approval for capital plans. Some of these institutions include Bank of America (BAC - Free Report) , JPMorgan (JPM - Free Report) and Goldman Sachs (GS - Free Report) .
Alongside share repurchase, the company is also active in dividend payments. Since 2011, U.S. Bancorp has been raising its dividend consistently. The company’s 2019 capital plan also included a 13.5% hike in quarterly dividend announced in September. Prior to this, it had raised its dividend by 23% last September.
U.S. Bancorp has returned 80% of its earnings to shareholders through dividends and share repurchases as of Sep 30 2019, which is at the higher end of the targeted payout ratio of 60-80%.
Our Take
Driven by a healthy liquidity position, U.S. Bancorp remains well poised to increase shareholders’ wealth through regular dividend payments and share buybacks. Further, the company’s capital-deployment activities look sustainable, given the lower debt/equity ratio compared with its peers, along with robust earnings strength.
Shares of the company have gained 28% so far this year compared with 29.5% growth recorded by the industry.
Currently, U.S Bancorp carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>